Skip to content
Back to Parent Page


Safe. Simple. Guaranteed.
VASCADE® vascular closure system provides rapid hemostasis for interventional and diagnostic procedures and is the only closure device proven safer than manual compression in a randomized clinical trial1 with zero major complications.2 The VASCADE system works by allowing your physician to deliver a collagen patch at the puncture site in the tissue surrounding the vessel. The precise placement of the collagen is accomplished by placing a small collapsible mesh disc against the inside of the vessel wall, which provides temporary hemostasis. Watch the video

Haemonetics Vascular Closure


Make a selection to learn more


Select an icon to learn more
Haemonetics Vascular Closure

— Proven safety & efficacy —

Benefits of using the VASCADE® System

• Simple-to-use technique with no sheath exchange to easily deploy collagen
• Unique design maintains collagen patch position during sleeve retraction and device removal
• Disc technology efficiently locates arteriotomy or venotomy for precise placement and release of pre-loaded patch
• Proven technology that has been used in more than 500,000 procedures
• Fully-integrated femoral access closure system

Ordering Information

To place an order please contact Customer Service.
Model NumberDescriptionOrder Quantity
800-612C-10U  6-12 French (Inner Diameter)1 Box (10 devices per box)
Model NumberDescriptionOrder Quantity
700-500DX-05U 5 French (Inner Diameter)1 Box (5 devices per box)
Model NumberDescriptionOrder Quantity
700-580I-05U 6/7 French (Inner Diameter)1 Box (5 devices per box)
Product NameModel NumberDescriptionOrder Quantity
500-580C-10U 5-7 French
1 Box (10 devices per box)
5-7 French
1 Box (10 devices per box) 
1. IFUs and / or SSEDs of commercially available leading brands (VASCADE, AngioSeal, Mynx, Perclose, Starclose, Exoseal).
2. Hermiller JB, A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients Journal of Invasive Cardiology 2015;27(3):129-136.

Connect with Vascular Closure

Haemonetics Vascular Closure LinkedIn    Haemonetics Vascular Closure Twitter